Abstract

Treatment of quiescent human embryonic lung fibroblastic cells (TIG-3) with 10 nM epidermal growth factor (EGF) resulted in 4-6-fold activation of a protein kinase activity in cell extracts that phosphorylated microtubule-associated protein 2 (MAP2) on serine and threonine residues in vitro. The half-maximal activation of the kinase activity occurred within 5 min after EGF treatment, and the maximal level was attained at 15 min. Casein and histone were very poor substrates for this EGF-stimulated MAP2 kinase activity. The activation of the kinase activity persisted after brief dialysis. Interestingly, the EGF-stimulated MAP2 kinase activity was sensitive to micromolar concentrations of free Ca2+; it was inhibited 50% by 0.5 microM Ca2+ and almost totally inhibited by 2 microM Ca2+. The activated MAP2 kinase activity was recovered in flow-through fractions on phosphocellulose column chromatography, while kinase activities that phosphorylate 40 S ribosomal protein S6 (S6 kinase activities) were mostly retained on the column and eluted at 0.5 M NaCl. Platelet-derived growth factor, fibroblast growth factor, insulin-like growth factor-I, insulin, phorbol esters (12-O-tetradecanoylphorbol 13-acetate and phorbol 12,13-dibutyrate), and fresh fetal calf serum also induced activation of the MAP2 kinase in the quiescent TIG-3 cells. The activated MAP2 kinase activity in cells stimulated by platelet-derived growth factor, fibroblast growth factor, insulin-like growth factor-I, insulin, 12-O-tetradecanoylphorbol 13-acetate, phorbol 12,13-dibutyrate, or fetal calf serum was almost completely inhibited by 2 microM Ca2+, like the EGF-stimulated kinase. In addition, MAP2 phosphorylated by the kinase activated by different stimuli gave very similar phosphopeptide mapping patterns. These results suggest that several growth factors, phorbol esters, and serum activate a common, Ca2+-inhibitable protein kinase which is distinct from S6 kinase in quiescent human fibroblasts.

Highlights

  • Treatment of quiescent human embryonic lung fibro- extracts using microtubule-associated protein 2 (MAP2)’ as blastic cells (TIG-3) with 10 n M epidermalgrowth an exogenous substrate

  • The activated MAP2 kinase activity was recovered in flow-through fractionsonphosphocellulosecolumn chromatography, ulin-dependent protein kinase (9-ll), casein kinase-1 [12], and protein kinase C (Ca” phospholipid-dependent enzyme) [13,14]

  • We have found that in 3Y1 cells stimcells stimulated by platelet-derived growth factor, fi- ulation by insulin-like growth factor-I(IGF-I)orplateletbroblast growth factor, insulin-like growth factor-I, derived growth factor (PDGF) induces the phosphorylainsulin, 12-0-tetradecanoylphorbol13-acetate, phor- tion of the 350,000 and 300,000 proteins and that the phosbo1 12,13-dibutyrate, or fetal calf serum was almost phopeptide maps of theseproteins derived from the cells completely inhibited by 2 PM Ca2’, like theEGF-stim- stimulated by insulin, IGF-I, TPA, PDGF, or EGF give very ulated kinase

Read more

Summary

Introduction

Treatment of quiescent human embryonic lung fibro- extracts using microtubule-associated protein 2 (MAP2)’ as blastic cells (TIG-3) with 10 n M epidermalgrowth an exogenous substrate. Ters, and serum activate a common, Ca2+-inhibitable threonine-specific protein kinase that phosphorylates MAP2 proteinkinase which is distinct from S6 kinasein in vitro is universally activated by several different growth quiescent human fibroblasts.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call